Keywords: Reimer Arzneimittel, Worldwide rights, Ostac, Roche, Metastatic bone lesions

Riemser strengthens oncology range with Roche drug

Article | 15 February 2012

Print This

German drugmaker Riemser Arzneimittel AG is extending its range of supportive cancer therapy products by purchasing the world-wide rights to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in